<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	>
<channel>
	<title>Comments on: Glaxo To Pay $1B To Settle Paxil Birth Defect Cases</title>
	<atom:link href="http://www.pharmalot.com/2010/07/glaxo-to-pay-1b-to-settle-paxil-birth-defect-cases/feed" rel="self" type="application/rss+xml" />
	<link>http://www.pharmalot.com/2010/07/glaxo-to-pay-1b-to-settle-paxil-birth-defect-cases/</link>
	<description>News, Comment and Conversation</description>
	<pubDate>Fri, 10 Feb 2012 21:40:15 +0000</pubDate>
	<generator>http://wordpress.org/?v=2.6.2</generator>
		<item>
		<title>By: Evelyn Pringle</title>
		<link>http://www.pharmalot.com/2010/07/glaxo-to-pay-1b-to-settle-paxil-birth-defect-cases/#comment-513716</link>
		<dc:creator>Evelyn Pringle</dc:creator>
		<pubDate>Thu, 22 Jul 2010 15:59:02 +0000</pubDate>
		<guid isPermaLink="false">http://www.pharmalot.com/?p=25031#comment-513716</guid>
		<description>Salmon - I'm sure many infants born to mothers who took Paxil while pregnant probably have neurodevelopmental problems but I bet they'll never get recognized for what they are. Sad.</description>
		<content:encoded><![CDATA[<p>Salmon - I&#8217;m sure many infants born to mothers who took Paxil while pregnant probably have neurodevelopmental problems but I bet they&#8217;ll never get recognized for what they are. Sad.</p>
]]></content:encoded>
	</item>
	<item>
		<title>By: Biotruth</title>
		<link>http://www.pharmalot.com/2010/07/glaxo-to-pay-1b-to-settle-paxil-birth-defect-cases/#comment-513583</link>
		<dc:creator>Biotruth</dc:creator>
		<pubDate>Thu, 22 Jul 2010 00:59:50 +0000</pubDate>
		<guid isPermaLink="false">http://www.pharmalot.com/?p=25031#comment-513583</guid>
		<description>Thanks for the feedback -</description>
		<content:encoded><![CDATA[<p>Thanks for the feedback -</p>
]]></content:encoded>
	</item>
	<item>
		<title>By: Salmon</title>
		<link>http://www.pharmalot.com/2010/07/glaxo-to-pay-1b-to-settle-paxil-birth-defect-cases/#comment-513565</link>
		<dc:creator>Salmon</dc:creator>
		<pubDate>Wed, 21 Jul 2010 21:36:47 +0000</pubDate>
		<guid isPermaLink="false">http://www.pharmalot.com/?p=25031#comment-513565</guid>
		<description>I would expect neurodevelopmental problems however, it's more difficult to support a claim as injuries could also be attributed to genetic factors.

Salmon</description>
		<content:encoded><![CDATA[<p>I would expect neurodevelopmental problems however, it&#8217;s more difficult to support a claim as injuries could also be attributed to genetic factors.</p>
<p>Salmon</p>
]]></content:encoded>
	</item>
	<item>
		<title>By: Evelyn Pringle</title>
		<link>http://www.pharmalot.com/2010/07/glaxo-to-pay-1b-to-settle-paxil-birth-defect-cases/#comment-513555</link>
		<dc:creator>Evelyn Pringle</dc:creator>
		<pubDate>Wed, 21 Jul 2010 19:37:55 +0000</pubDate>
		<guid isPermaLink="false">http://www.pharmalot.com/?p=25031#comment-513555</guid>
		<description>I've been covering the SSRI birth defect litigation almost since it began and I have never heard of a case alleging neurodevelopmental injuries. I think they are mostly wrongful deaths, heart defects or a lung disorder.  

Other injuries could have been added in the last year or so that I may not have heard about, but I think I would have.</description>
		<content:encoded><![CDATA[<p>I&#8217;ve been covering the SSRI birth defect litigation almost since it began and I have never heard of a case alleging neurodevelopmental injuries. I think they are mostly wrongful deaths, heart defects or a lung disorder.  </p>
<p>Other injuries could have been added in the last year or so that I may not have heard about, but I think I would have.</p>
]]></content:encoded>
	</item>
	<item>
		<title>By: Biotruth</title>
		<link>http://www.pharmalot.com/2010/07/glaxo-to-pay-1b-to-settle-paxil-birth-defect-cases/#comment-513551</link>
		<dc:creator>Biotruth</dc:creator>
		<pubDate>Wed, 21 Jul 2010 19:13:14 +0000</pubDate>
		<guid isPermaLink="false">http://www.pharmalot.com/?p=25031#comment-513551</guid>
		<description>One may wonder if any of the OB-GYNs cautioned their patients about SSRI use during their pregnancy (especially during first trimester). The association of a pregnant woman’s first trimester paroxetine (Paxil) exposure with an increased risk of cardiovascular malformations, mostly ventricular (VSDs) and atrial septal defects (ASDs) has been documented. 

Question: do any of these lawsuits involving “birth defects” mention neurodevelopmental problems in the children (or did they focus specifically on cardio defects)? 

I raise this question because of the newest concern that SSRIs may be associated with autism (by disrupting 5HT homeostasis during early brain development). 
  
Almost exactly 2 years ago, Dr. Rick Lin and his colleagues at the University of Mississippi’s Autism Spectrum Disease Research Group (ASDRG) were awarded a prestigious four-year, $1.2 million grant from NIH, known as a grant from the EUREKA program (Exceptional, Unconventional Research Enabling Knowledge Acceleration Program). This grant addresses an unconventional and compelling idea that the *rise in autism may be due (in part?) to the rise in the use of SSRI anti-depressant drugs.* Clearly, NIH paid attention.  

“The group’s central hypothesis (from data based initially on rat moms and their pups) is that abnormal regulation of serotonin (5HT) during early brain development compromises oligodendrocyte function and interferes with the establishment of normal interhemispheric connections.” – from their website at  http://www.umhc.com/wtn/Page.asp?PageID=WTN000064

This group hypothesizes that abnormal levels of serotonin during pregnancy (as a consequence of the pregnant human mom taking SSRIs) may be “the key environmental factor contributing to the recent surge of autism not only in the United States, but also in other highly developed, industrialized countries.”</description>
		<content:encoded><![CDATA[<p>One may wonder if any of the OB-GYNs cautioned their patients about SSRI use during their pregnancy (especially during first trimester). The association of a pregnant woman’s first trimester paroxetine (Paxil) exposure with an increased risk of cardiovascular malformations, mostly ventricular (VSDs) and atrial septal defects (ASDs) has been documented. </p>
<p>Question: do any of these lawsuits involving “birth defects” mention neurodevelopmental problems in the children (or did they focus specifically on cardio defects)? </p>
<p>I raise this question because of the newest concern that SSRIs may be associated with autism (by disrupting 5HT homeostasis during early brain development). </p>
<p>Almost exactly 2 years ago, Dr. Rick Lin and his colleagues at the University of Mississippi’s Autism Spectrum Disease Research Group (ASDRG) were awarded a prestigious four-year, $1.2 million grant from NIH, known as a grant from the EUREKA program (Exceptional, Unconventional Research Enabling Knowledge Acceleration Program). This grant addresses an unconventional and compelling idea that the *rise in autism may be due (in part?) to the rise in the use of SSRI anti-depressant drugs.* Clearly, NIH paid attention.  </p>
<p>“The group’s central hypothesis (from data based initially on rat moms and their pups) is that abnormal regulation of serotonin (5HT) during early brain development compromises oligodendrocyte function and interferes with the establishment of normal interhemispheric connections.” – from their website at  <a href="http://www.umhc.com/wtn/Page.asp?PageID=WTN000064" rel="nofollow">http://www.umhc.com/wtn/Page.asp?PageID=WTN000064</a></p>
<p>This group hypothesizes that abnormal levels of serotonin during pregnancy (as a consequence of the pregnant human mom taking SSRIs) may be “the key environmental factor contributing to the recent surge of autism not only in the United States, but also in other highly developed, industrialized countries.”</p>
]]></content:encoded>
	</item>
	<item>
		<title>By: Matthew Holford</title>
		<link>http://www.pharmalot.com/2010/07/glaxo-to-pay-1b-to-settle-paxil-birth-defect-cases/#comment-513525</link>
		<dc:creator>Matthew Holford</dc:creator>
		<pubDate>Wed, 21 Jul 2010 15:46:18 +0000</pubDate>
		<guid isPermaLink="false">http://www.pharmalot.com/?p=25031#comment-513525</guid>
		<description>""GSK believes it acted properly and responsibly in conducting its clinical trial program, in marketing the medicine, in monitoring its safety once it was approved for use and in updating pregnancy information in the medicine’s label as new information became available," a Glaxo spokeswoman tells Bloomberg."

Out of interest, you wouldn't happen to know whether this "spokeswoman" was Mary-Anne Rhyne would you, Ed?

Anyway, importantly, an out-of-court settlement permits denial of all responsibility (as would a civil decision in favour of a plaintiff patient, in truth), and any further questions may be dismissed with "that's all settled, so you can forget about it, because we have," and the Company won't have to change the way it operates, at all, as though everything really were settled.  Great system!

Mind you, the issue of side effects, whilst I wouldn't wish to diminish it, is secondary to whether the drug works, because if it doesn't actually make people better, then the question of side effects should never arise.  So, as a parting shot, does GSK believe that its drug has a level of efficacy that outstrips placebo, outside that presumed to be present solely on the basis that it has a marketing authorization (licence)?  Because, obviously, GSK is big into beliefs, and is confident in putting its beliefs forward for scrutiny.  So, let's have at it, I say.

Matt</description>
		<content:encoded><![CDATA[<p>&#8220;&#8221;GSK believes it acted properly and responsibly in conducting its clinical trial program, in marketing the medicine, in monitoring its safety once it was approved for use and in updating pregnancy information in the medicine’s label as new information became available,&#8221; a Glaxo spokeswoman tells Bloomberg.&#8221;</p>
<p>Out of interest, you wouldn&#8217;t happen to know whether this &#8220;spokeswoman&#8221; was Mary-Anne Rhyne would you, Ed?</p>
<p>Anyway, importantly, an out-of-court settlement permits denial of all responsibility (as would a civil decision in favour of a plaintiff patient, in truth), and any further questions may be dismissed with &#8220;that&#8217;s all settled, so you can forget about it, because we have,&#8221; and the Company won&#8217;t have to change the way it operates, at all, as though everything really were settled.  Great system!</p>
<p>Mind you, the issue of side effects, whilst I wouldn&#8217;t wish to diminish it, is secondary to whether the drug works, because if it doesn&#8217;t actually make people better, then the question of side effects should never arise.  So, as a parting shot, does GSK believe that its drug has a level of efficacy that outstrips placebo, outside that presumed to be present solely on the basis that it has a marketing authorization (licence)?  Because, obviously, GSK is big into beliefs, and is confident in putting its beliefs forward for scrutiny.  So, let&#8217;s have at it, I say.</p>
<p>Matt</p>
]]></content:encoded>
	</item>
</channel>
</rss>

<!-- Dynamic Page Served (once) in 0.156 seconds -->

